Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

SurModics Inc Appoints Andy LaFrence As Chief Financial Officer


Friday, 21 Dec 2012 04:01pm EST 

SurModics Inc announced the appointment of Andy LaFrence as the company's Vice President of Finance and Chief Financial Officer, effective February 12, 2013. He will lead all of the financial activities of SurModics, including controlling, financial planning and analysis, treasury, tax, audit and investor relations. LaFrence will succeed Timothy Arens, who currently serves as interim Chief Financial Officer. Arens will remain with the Company and will transition into the role of Vice President of Corporate Development and Strategy. In his new role, Mr. Arens will lead the Company's efforts in developing strategies and assessing growth opportunities for its Medical Device and In Vitro Diagnostics businesses. 

Company Quote

18.81
0.33 +1.79%
18 Sep 2014